# Design, Synthesis, and Structure–Activity Relationships of Substituted Phenyl Cyclobutylureas as Potential Modulators of Inflammatory Responses

**Authors:** Atziri Corin Chavez Alvarez, Antoine Carpentier, Ahmed Sahli, Martin Perreault, Aichatou Diallo Ngon, Emmanuel Moreau

PMC · DOI: 10.3390/ph19030355 · Pharmaceuticals · 2026-02-25

## TL;DR

This paper explores new chemical compounds that may help control inflammation, focusing on their design and early biological testing.

## Contribution

The study introduces and evaluates novel arylurea derivatives as potential anti-inflammatory agents with promising preliminary results.

## Key findings

- Twenty-three ACBU derivatives were synthesized and evaluated for anti-inflammatory activity.
- Compounds 4b, 10b, and 16b showed favorable profiles in preliminary assays.
- Docking studies provided insights to guide further chemical optimization.

## Abstract

Background/Objectives: Chronic inflammation underlies many immune-mediated conditions, yet current anti-inflammatory therapies are often limited by incomplete efficacy or safety concerns. Small molecules inspired by soluble epoxide hydrolase (sEH) inhibitors represent a promising scaffold for early-stage exploration. This study describes the design, synthesis, and preliminary biological evaluation of three series of arylurea derivatives (ACBUs) to establish structure–activity relationships and guide chemical optimization. Methods: The compounds were assessed for effects on keratinocyte proliferation, human sEH activity, and the expression of selected inflammatory markers using IL-17A/TNF-α-stimulated HaCaT cells, a relevant in vitro model for preliminary anti-inflammatory profiling. Results: A total of 23 novel ACBU derivatives were synthesized and evaluated. Most compounds showed low antiproliferative activity, allowing selection based on cytotoxicity and solubility. Compounds 4b, 10b, and 16b consistently displayed the most favorable profiles in these preliminary assays. Docking studies provided structural rationales supporting the observed trends and guided further optimization within the series. Conclusions: Compound 4b emerged as the most active candidate in preliminary screening, serving as a reference for ongoing SAR studies. These results highlight the potential of the arylurea scaffold for further chemical optimization and demonstrate the value of early-stage biological profiling in guiding our further studies.

## Linked entities

- **Proteins:** EPHX2 (epoxide hydrolase 2), IL17A (interleukin 17A), TNF (tumor necrosis factor)
- **Chemicals:** 10b (PubChem CID 6337058)

## Full-text entities

- **Genes:** EPHX2 (epoxide hydrolase 2) [NCBI Gene 2053] {aka ABHD20, CEH, SEH}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}
- **Diseases:** Chronic inflammation (MESH:D007249), cytotoxicity (MESH:D064420)
- **Chemicals:** ACBUs (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029360/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13029360/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029360/full.md

---
Source: https://tomesphere.com/paper/PMC13029360